Alnylam Pharmaceuticals (ALNY.MX) Q4 2013 Earnings

6NovConfirmed
Q1 1
Q3 2013
Q4 2013
-27.2
-19.35
-11.5
-3.65

Details

Expected EPS
N/A
Actual EPS
-6.318912
Surprise EPS
-6.32
Surprise Percent
+∞%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -6.318912 per share for Q4 2013.

0 Comments

Share your thoughts